tirzepatide heart health Weight-loss drug may lower failure deaths Tirzepatide cuts heart failure risk
Description
Many people achieve excellent results at 8mg with better tolerability
doi: 10.1186/s12967-021-02901-7
Readers are encouraged to verify all details directly with TrimRx and their healthcare provider before making decisions
When you stop or reduce the medication, the brain can become imbalanced, leading to physical and mental setbacks
Its a sign that tirzepatide's powerful appetite-suppressing and glucose-regulating effects are creating a caloric deficit significant enough to trigger this fundamental metabolic change
The STEP 1 trial (Wilding et al., NEJM 2021) demonstrated an average 14.9% body weight reduction with semaglutide 2.4mg weekly over 68 weeks, compared to 2.4% with placebo a magnitude of effect that no prior anti-obesity medication had achieved
